Measuring the Serological Response to SARS-CoV-2: Methods and Meaning

dc.creatorPecora, Nicole D.
dc.creatorZand, Martin S.
dc.date.accessioned2020-08-18T20:58:45Z
dc.date.accessioned2022-09-23T18:23:34Z
dc.date.available2020-08-18T20:58:45Z
dc.date.available2022-09-23T18:23:34Z
dc.date.created2020-08-18T20:58:45Z
dc.identifier0272-2712
dc.identifierhttps://doi.org/10.1016/j.cll.2020.08.014
dc.identifierhttp://hdl.handle.net/20.500.12010/11944
dc.identifierhttps://doi.org/10.1016/j.cll.2020.08.014
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3499976
dc.description.abstractThe COVID-19 pandemic began in December 2019 with several cases of a pneumonia of unknown etiology in Wuhan, China 1 . The causative agent was quickly identified using molecular techniques as the Betacoronavirus SARS-CoV-2 2 . This discovery was followed by a global effort to develop accurate molecular diagnostics at tremendous scale and pace in order to diagnose acute infection and contain spread of the virus. Questions about serological testing followed soon after
dc.publisherCLINICS IN LABORATORY MEDICINE
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.rightsAcceso restringido
dc.sourcereponame:Expeditio Repositorio Institucional UJTL
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozano
dc.subjectSARS-CoV-2
dc.subjectCOVID-19
dc.subjectCOVID-19 serology
dc.titleMeasuring the Serological Response to SARS-CoV-2: Methods and Meaning


Este ítem pertenece a la siguiente institución